| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Mar 10, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) invites the public to access a webcast of Chairman, President and CEO, Dave Gibbons' presentation at the Bank of America 2006 Consumer Conference on...
-
Mar 7, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture and market Ciclopirox Olamine Cream USP,...
-
Mar 2, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that Chief Financial Officer Douglas R. Schrank will retire from his post on June 30, 2006. Judy L. Brown, Senior Vice President and...
-
Feb 22, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that, through a partnership with InvaGen Pharmaceuticals, it has received tentative approval from the U.S. Food and Drug...
-
Feb 21, 2006Authorizes Extension of Share Repurchase Program
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced the appointment by the Board of Directors of Ran Gottfried as a new director of the Company. Mr. Gottfried was appointed to serve for...
-
Feb 15, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its Board of Directors declared a quarterly dividend of $0.0425 per share, payable on March 21, 2006 to shareholders of record...
-
Feb 2, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market over-the-counter (OTC) nicotine polarcrilex...
-
Feb 2, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced results for the second quarter of fiscal year 2006 ended Dec. 24, 2005. The acquisition of Agis Industries was completed on March 17,...
-
Jan 27, 2006
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it will release financial results for its second quarter fiscal 2006 on Thursday, Feb. 2, 2006 at approximately 8:30 a.m. (ET). The...
-
Jan 10, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture and market Desoximetasone Gel USP,...
-
Oct 28, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its Board of Directors declared a quarterly dividend of $0.0425 per share, payable on December 20, 2005 to shareholders of...
-
Oct 27, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced results for the first quarter of fiscal year 2006 ended Sept. 24, 2005. The acquisition of Agis Industries was completed on March 17,...
-
Oct 25, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its Perrigo Israel Pharmaceuticals Ltd. (formerly Agis Industries (1983) Ltd.) subsidiary is challenging the patent submitted to...
-
Oct 20, 2005
SCOLR Pharma, Inc. (AMEX: DDD) and Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that they entered into an agreement whereby Perrigo will manufacture and market certain sustained...
-
Oct 20, 2005
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it will release financial results for its first quarter fiscal 2006 on Thursday, Oct. 27, 2005 at approximately 8:30 a.m. (ET). The...
-
Oct 7, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced that through a partnership with InvaGen Pharmaceuticals, it has received final approval from the U.S. Food and Drug Administration (FDA) to...
-
Sep 21, 2005
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announces the following Webcast: What: Perrigo Analysts' Meeting When: Thursday, September 22, 2005, 9:00 a.m. - Noon (ET) And Friday, September 23,...
-
Sep 12, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has received tentative approval from the U.S. Food and Drug Administration to manufacture and market Famotidine Tablets USP,...
-
Sep 7, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced results for the full year and fourth quarter ended June 25, 2005. The acquisition of Agis Industries was completed on March 17, 2005....
-
Aug 29, 2005
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it will release financial results for its fourth quarter and fiscal year 2005 on Wednesday, Sept. 7, 2005 at approximately 8:30 a.m....
-
Aug 25, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that, through a partnership with InvaGen Pharmaceuticals, it has received tentative approval from the U.S. Food and Drug...
-
Aug 5, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its Board of Directors declared a quarterly dividend of $0.04 per share, payable on September 20, 2005 to shareholders of record...
-
Jul 19, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture and market prescription Ibuprofen...
-
Jun 24, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture and market over-the- counter (OTC)...
-
Jun 16, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has adopted a written trading plan under Rule 10b5-1 of the Securities Exchange Act of 1934 to facilitate the repurchase of...
-
May 5, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced results for the third quarter and nine months of fiscal 2005 ended March 26, 2005. Perrigo Company (in thousands, except per share...
-
Apr 28, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture and market Naproxen Tablets USP, 250...
-
Apr 28, 2005
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it will release financial results for its third quarter on Thursday, May 5, 2005 at approximately 8:30 a.m. (ET). The Company will...
-
Apr 26, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its Board of Directors has authorized the repurchase of up to $30 million of the Company's common stock over the next 12 months....
-
Apr 22, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its Board of Directors declared a quarterly dividend of $0.04 per share, payable on June 21, 2005 to shareholders of record on...
-
Apr 11, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its Agis Industries subsidiary has received approval from the U.S. Food and Drug Administration (FDA) to manufacture and market...
-
Mar 17, 2005Creates global provider of generic prescription drugs, active pharmaceutical ingredients and consumer healthcare products
The Perrigo Company (NASDAQ: PRGO) today announced the completion of its acquisition of Agis Industries (1983) Ltd., a developer and manufacturer of specialized generic pharmaceuticals and active...
-
Mar 15, 2005
The Perrigo Company (NASDAQ: PRGO) announced today that its shareholders approved the issuance of shares of Perrigo common stock in connection with the November 14, 2004 agreement and plan of...
-
Feb 4, 2005
The Perrigo Company (NASDAQ: PRGO) today announced that its Board of Directors declared a quarterly dividend of $0.04 per share, payable on March 22, 2005 to shareholders of record on February 25,...
-
Feb 1, 2005
The Perrigo Company (NASDAQ: PRGO) today announced results for the second quarter and six months of fiscal 2005 ended Dec. 25, 2004. Perrigo Company (in thousands, except per share amounts) Second...
-
Jan 28, 2005
Perrigo Company (NASDAQ: PRGO) today announced that it will release financial results for its second quarter on Tuesday, Feb. 1, 2005 at approximately 8:30 a.m. (ET). The Company will conduct a...
-
Nov 3, 2004
Bentley Pharmaceuticals, Inc. (NYSE: BNT), a technology-based specialty pharmaceuticals and drug delivery company, and Perrigo Company (NASDAQ: PRGO), the nation's largest manufacturer of...
-
Oct 29, 2004
The Perrigo Company (NASDAQ: PRGO) today announced that its Board of Directors declared a quarterly dividend of $0.04 per share, payable on December 21, 2004 to shareholders of record on November...
-
Oct 26, 2004
The Perrigo Company (NASDAQ: PRGO) today announced results for the first quarter of fiscal 2005 ended Sept. 25, 2004. Perrigo Company (In thousands, except per share amounts) Fiscal 2005 Fiscal...
-
Oct 20, 2004
Perrigo Company (NASDAQ: PRGO) today announced that it will release financial results for its first quarter on Tuesday, October 26, 2004 at approximately 8:30 a.m. (ET). The Company will conduct a...
-
Oct 5, 2004
The Perrigo Company (NASDAQ: PRGO) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market over-the-counter (OTC) nicotine polacrilex gum and...
-
Aug 10, 2004
The Perrigo Company (NASDAQ: PRGO) today announced results for the full year and fourth quarter ended June 26, 2004. Perrigo Company (in thousands, except per share amounts) Fourth Quarter...
-
Aug 6, 2004
The Perrigo Company (NASDAQ: PRGO) today announced that its Board of Directors declared a quarterly dividend of $0.035 per share, payable on September 21, 2004, to shareholders of record on August...
-
Aug 4, 2004
Perrigo Company (NASDAQ: PRGO) today announced that it will release financial results for its fourth quarter and year-end on Tuesday, August 10, 2004 at approximately 8:30 a.m. (ET). The Company...
-
Aug 3, 2004
Today the Perrigo Company (NASDAQ: PRGO) announced that it is negotiating a settlement with the U.S. Federal Trade Commission (FTC) in order to close the FTC's investigation into a 1998 agreement...
-
Jul 15, 2004
The Perrigo Company (NASDAQ: PRGO) announced today that it has entered into a purchase agreement to acquire certain assets of APG, Inc., a privately-owned contract manufacturer and packager of...
-
Jun 10, 2004
The Perrigo Company (NASDAQ: PRGO) said today that it had completed a review of the May 2004 contract between Lannett Company, Inc. (AMEX: LCI) and Jerome Stephens Pharmaceutical, Inc. (JSP). As...
-
May 6, 2004
Perrigo Company (NASDAQ: PRGO) said today that Lannett Company, Inc. (AMEX: LCI) announced it has signed a supply agreement with Jerome Stevens Pharmaceuticals, Inc. (JSP) for the exclusive...
-
Apr 30, 2004
The Perrigo Company (NASDAQ: PRGO) today announced that its Board of Directors declared a quarterly dividend of $0.035 per share, payable on June 22, 2004, to shareholders of record on May 28,...
-
Apr 23, 2004Revenues Increase 14 Percent; Net Income Increases 26 Percent To $17.7 Million
The Perrigo Company (NASDAQ: PRGO) today announced results for the third quarter and nine months of fiscal 2004 ended March 27, 2004. Perrigo Company (in thousands, except per share amounts) Third...
-
Apr 16, 2004
Perrigo Company (NASDAQ: PRGO) today announced that it will release financial results for its third quarter on Friday, April 23, 2004 at approximately 8:30 a.m. (ET). The Company will conduct a...
-
Mar 31, 2004
The Perrigo Company (NASDAQ: PRGO) invites the public to access a webcast of the Company's presentation at the Banc of America Securities Consumer Conference on Thursday, April 1 at 10:50 a.m....
-
Dec 12, 2003
The Perrigo Company (NASDAQ: PRGO) today announced it has acquired Peter Black Pharmaceuticals, Ltd. for approximately $13 million in cash. Based in Swadlincote, United Kingdom, privately held...
-
Nov 14, 2003
The Perrigo Company (NASDAQ: PRGO) today announced that it will begin marketing three new products following U.S. Food and Drug Administration (FDA) approvals. More specifically, these new...
-
Nov 14, 2003
The Perrigo Company (NASDAQ: PRGO) announced today that, as Alpharma Inc. reported in its 10-Q, the U.S. Federal Trade Commission is investigating a 1998 agreement between Alpharma and Perrigo....
-
Oct 29, 2003
The Perrigo Company (NASDAQ: PRGO) today announced that its Board of Directors has authorized the repurchase of an additional $20 million of the Company's common stock under its ongoing share...
-
Oct 28, 2003
The Perrigo Company (NASDAQ: PRGO) today announced that its Board of Directors declared a quarterly dividend of $.035 per share, payable on December 23, 2003 to shareholders of record on November...
-
Oct 24, 2003
The Perrigo Company (NASDAQ: PRGO) today announced results for the first quarter of fiscal 2004 ended September 27, 2003. Perrigo Company (NASDAQ: PRGO) (In thousands, except per share amounts)...
-
Oct 21, 2003
Perrigo Company (NASDAQ: PRGO) today announced that it will release financial results for its first quarter on Friday, October 24, 2003 at approximately 8:30 a.m. ET. The Company will conduct a...
-
Sep 3, 2003Signs Licensing Agreement With Sierra Medicinals of the StarMed Group
The Perrigo Company (NASDAQ: PRGO) announced today it has signed a licensing agreement with Sierra Medicinals, Inc. to manufacture and market the Dr. Steven Rosenblatt brand dietary supplement,...
-
Sep 2, 2003
Perrigo Company (NASDAQ: PRGO) announced today that Todd Kingma has joined the company as Vice President & General Counsel, replacing Jack Nichols who will be retiring next year after 10 years as...
-
Aug 11, 2003
The Perrigo Company (NASDAQ: PRGO) today announced that its Board of Directors has elected David T. Gibbons, President and Chief Executive Officer, to the additional responsibility of Chairman of...
-
Aug 11, 2003
The Perrigo Company (NASDAQ: PRGO) today announced results for the full year and fourth quarter ended June 28, 2003. Perrigo Company (NASDAQ: PRGO) (in thousands, except per share amounts) Fourth...
-
Aug 7, 2003
Perrigo Company (NASDAQ: PRGO) today announced that it will release financial results for its fourth quarter and fiscal 2003 year end on Monday, August 11, 2003 at approximately 8:30 a.m. EDT. The...
-
Aug 7, 2003
The Board of Directors of Perrigo Company (NASDAQ: PRGO) today declared a regular quarterly dividend of $0.025 per share, payable on September 23, 2003, to shareholders of record on August 29,...
-
May 9, 2003
The Board of Directors of Perrigo Company (NASDAQ: PRGO) today declared a regular quarterly dividend of $0.025 per share, payable on June 24, 2003, to shareholders of record on May 30, 2003....
-
Apr 23, 2003
The Perrigo Company (NASDAQ: PRGO) today announced results for the third quarter and nine months of fiscal 2003 ended March 29, 2003. Perrigo Company (NASDAQ: PRGO) (in thousands, except per share...
-
Apr 17, 2003
Perrigo Company (NASDAQ: PRGO) today announced that it will release financial results for its third quarter fiscal 2003 on Wednesday, April 23, 2003 at approximately 8:30 a.m. EDT. The Company...
-
Mar 28, 2003
The Perrigo Company (NASDAQ: PRGO) invites the public to access a webcast of the Company's presentation at the Banc of America Securities Consumer Conference on Wednesday, April 2 at 2:40 p.m. (EST).
-
Jan 27, 2003
Andrx Corporation (NASDAQ: ADRX) and Perrigo Company (NASDAQ: PRGO) today announced that they have entered into a multi-year agreement whereby Andrx will manufacture and supply Perrigo with...
-
Jan 27, 2003Elects To Expense Stock Option Compensation
The Perrigo Company (NASDAQ: PRGO) today announced results for the second quarter and six months of fiscal 2003 ended December 28, 2002. Perrigo Company (NASDAQ: PRGO) (in thousands, except per...
-
Jan 24, 2003
The Perrigo Company (NASDAQ: PRGO) today announced the appointment of two new independent directors to its Board of Directors. The new directors are Gary M. Cohen, President, BD Medical Systems,...
-
Jan 23, 2003
The Perrigo Company (NASDAQ: PRGO) today announced that its Board of Directors adopted a policy of paying regular quarterly dividends and declared a quarterly dividend of $0.025 per share, payable...
-
Jan 22, 2003
Perrigo Company (NASDAQ: PRGO) today announced that it will release financial results for its second quarter fiscal 2003 on Monday, January 27, 2003 at approximately 8:30 a.m. EST. The Company...
-
Oct 29, 2002
The Perrigo Company (NASDAQ: PRGO) announced today the appointment by the Board of Directors of Gary K. Kunkle, Jr. as a new director of the Company. Mr. Kunkle was appointed to fill a vacancy and...
-
Oct 24, 2002
The Perrigo Company (NASDAQ: PRGO) today announced results for the first quarter of fiscal 2003 ended September 28, 2002. Perrigo Company (NASDAQ: PRGO) (In thousands, except per share amounts)...
-
Oct 21, 2002
Perrigo Company (NASDAQ: PRGO) today announced that it will release financial results for its first quarter fiscal 2003 on Thursday, October 24, 2002 at approximately 8:30 a.m. EDT. The Company...
-
Oct 7, 2002
The Perrigo Company (NASDAQ: PRGO) invites the public to access a webcast of the Company's presentation at the McDonald Investments Consumer Conference on Wednesday, October 9 at 1:30 p.m. (EDT)....
-
Aug 20, 2002
The Perrigo Company (NASDAQ: PRGO) today announced that its Board of Directors has authorized the repurchase of an additional $20 million of the Company's common stock under its ongoing share...
-
Aug 2, 2002
The Perrigo Company (NASDAQ: PRGO) today announced financial results for the full year and fourth quarter ended June 29, 2002. Fiscal Year 2002 For fiscal 2002, Perrigo's sales increased 10...
-
Jul 30, 2002
Perrigo Company (NASDAQ: PRGO) announces the following Webcast: What: Perrigo's 2002 Fourth Quarter and Year-End Earnings Release When: Friday, August 2, 2002 at 11 a.m. Eastern Where:...
-
Jul 17, 2002
The Perrigo Company (NASDAQ: PRGO) today announced that its Board of Directors has authorized the repurchase of an additional $20 million of the Company's common stock under its ongoing share...
-
Apr 25, 2002
Perrigo Company (NASDAQ: PRGO) today announced results for the third quarter and nine months ended March 30, 2002. Net sales for the third quarter were $198.5 million, an increase of four percent...
-
Apr 23, 2002
Perrigo Company (NASDAQ: PRGO) today announced that it will release financial results for its third quarter fiscal 2002 on Thursday, April 25, 2002 at approximately 8:30 a.m. EDT. The Company will...
-
Apr 5, 2002
The Perrigo Company (NASDAQ: PRGO) invites the public to access a webcast of the Company's presentation at the Banc of America Securities Consumer Conference on Monday, April 8 at 3:30 p.m. (EDT)....
-
Apr 4, 2002
The Perrigo Company (NASDAQ: PRGO), the nation's leading manufacturer of store brand over-the-counter pharmaceuticals, vitamins and nutritional supplements, announced today that it is the first...
-
Jan 23, 2002
Perrigo Company (NASDAQ: PRGO) today announced results for the second quarter and six months ended December 29, 2001. Net sales for fiscal 2002's second quarter increased 21 percent to $228.7...
-
Jan 21, 2002
Perrigo Company (NASDAQ: PRGO) today announced that it will release financial results for its second quarter fiscal 2002 ended December 29, 2001, on Wednesday, January 23, 2002 at approximately...
-
Dec 4, 2001
The Perrigo Company (NASDAQ: PRGO) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture and market over-the-counter (OTC) tioconazole...
-
Oct 23, 2001
Perrigo Company (NASDAQ: PRGO) today announced results for the first quarter of fiscal 2002 ended September 29, 2001. Net sales for fiscal 2002's first quarter increased 13 percent to $217.1...
-
Oct 19, 2001
Perrigo Company (NASDAQ: PRGO) today announced that it will release financial results for its fiscal 2002 first quarter ended September 29, 2001, on Tuesday, October 23, 2001 at approximately 8:30...
-
Oct 11, 2001
The Perrigo Company (NASDAQ: PRGO) today announced that its Board of Directors has authorized the repurchase of an additional $20 million of the Company's common stock under its ongoing share...
-
Aug 15, 2001
Perrigo Company today announced that, in cooperation with the U.S. Food and Drug Administration (FDA), it is conducting a recall of 7,788 four-ounce bottles of cherry-flavored pain reliever...
-
Aug 15, 2001
Perrigo Company (NASDAQ: PRGO) today announced results for the fourth quarter and fiscal year ended June 30, 2001. For the fourth quarter, net sales were $180.9 million, an increase of 19 percent...
-
Aug 2, 2001
Perrigo Company (NASDAQ: PRGO) today announced preliminary results for the Company's fiscal 2001 fourth quarter, which ended June 30, 2001. For the fourth quarter, Perrigo expects to report net...
-
Jun 29, 2001
The Perrigo Company (NASDAQ: PRGO) today announced it has acquired Wrafton Laboratories Ltd., a store brand supplier to grocery and pharmacy retailers in the U.K. and a contract manufacturer of...
-
Jun 7, 2001
The Perrigo Company (NASDAQ: PRGO) today announced that it has received approval to market and distribute Ibuprofen and Pseudoephedrine Hydrochloride Tablets USP, 200 mg and 30 mg respectively,...
-
Jun 1, 2001
The Perrigo Company (NASDAQ: PRGO) today announced that it will shortly begin shipping Famotidine 10 mg tablets through an agreement with Teva Pharmaceutical Industries Ltd. The terms of the...
-
Jun 1, 2001
The Perrigo Company (NASDAQ: PRGO) today announced an agreement to purchase Wrafton Laboratories Ltd., a subsidiary of McBride plc (LONDON: MCB) for $44 million. Wrafton Laboratories is a supplier...
-
May 18, 2001
The Perrigo Company (NASDAQ: PRGO) today announced that its presentation scheduled for Wednesday, May 23, 2001 at 8 a.m. EDT at the UBS Warburg Global Specialty Pharmaceuticals Conference in New...